Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
What happened
Those who may qualify for GLP-1 receptor agonistssuch as Ozempic, Wegovy, Mounjaro and Zepboundtypically include individuals with a Body Mass Index (BMI) of 30 or higher, or 27 and above with weight-related conditions such as hypertension, high cholesterol or sleep apnea
PlexusDx's Precision Peptide Genetic Test identifies your variants in GIPR rs1800437, which determine how sensitively your body responds to GLP-1 and GIP receptor activation
Tips for Staying on Track Set a Phone Alarm: Use a recurring weekly alarm that includes the name of the medication
It is a fat-reduction injectable, not a weight-loss treatment, so it is designed for a defined pocket of fat rather than general slimming
When you find a routine that works for you and is maintainable, it becomes a lifestyle rather than a temporary fix
